Understanding New Take-Home Methadone Rules
Take-home expansion: Scope and impact study (THESIS)
This research looks at how recent changes to take-home methadone rules are affecting people receiving treatment for opioid use disorder.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Friends Research Institute, INC. NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-11118963 on NIH RePORTER |
What this research studies
For many years, federal rules made it difficult for patients to get take-home methadone, requiring frequent clinic visits. Recently, these rules changed to allow more flexibility, letting clinics offer more take-home doses to help reduce crowding and make treatment easier to access. This project wants to understand how these new rules are being put into practice at clinics across the country. We also want to see how these changes are impacting patient outcomes and develop ways to predict who can safely receive take-home methadone.
Who could benefit from this research
Good fit: This research focuses on patients who are currently receiving methadone treatment for opioid use disorder.
Not a fit: Patients not receiving methadone or those without opioid use disorder would not directly benefit from this particular research.
Why it matters
Potential benefit: If successful, this work could lead to more flexible and accessible methadone treatment, making it easier for patients to manage their opioid use disorder.
How similar studies have performed: The recent regulatory changes are new, so this research is novel in its approach to understanding their real-world impact on patient care and outcomes.
Where this research is happening
Baltimore, United States
- Friends Research Institute, INC. — Baltimore, United States (Active)
Researchers
- Principal investigator: Gryczynski, Jan — Friends Research Institute, INC.
- Study coordinator: Gryczynski, Jan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.